Abstract
Idiopathic Granulomatous Mastitis (IGM) is a disease that clinically mimics breast cancers with symptoms of pain, edema, erythema, nipple discharge, nipple retraction, and fistula. Although IGM is considered to be formed by autoimmune responses or infections, the molecular mechanism behind formation and progress is unknown. Therefore, in this study, we aimed to investigate molecular mechanisms underlying IGM formation, progress, and recurrence by monitoring the changes at the proteome level. Protein extracts prepared from IGM (n = 15) and within-control tissues (n = 15) were subjected to nHPLC followed by LC–MS/MS proteomic analysis. Label-free quantitation analysis revealed that sixty differentially regulated between the two groups. Those proteins were classified based on their role in metabolic pathways using bioinformatics tools. Based on DAVID analysis, 16 of the differently regulated proteins were associated with the immune system, while 17 proteins were involved in cancer metabolism. STRING analysis showed that five of the differentially regulated proteins were associated with combined immune deficiency which were PNP, TAP1, ITGAL, PRKDC, and PTPRC while the other proteins were involved in insulin response and neutrophil degranulation. This study is one of the very few studies that investigated the changes in protein expressions of IGM tissues compared to controls. For the first time, we have shown the relationship of IGM with the immune system at the protein level and also underlined the cancer-like behavior of the disease. Furthermore, the proteins that were pointed out as combined immune deficiency-related proteins may have value as diagnostic markers for idiopathic granulomatous mastitis although further studies are needed to shed more light on the pathogenesis of the disease.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12032-022-01845-2/MediaObjects/12032_2022_1845_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12032-022-01845-2/MediaObjects/12032_2022_1845_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12032-022-01845-2/MediaObjects/12032_2022_1845_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12032-022-01845-2/MediaObjects/12032_2022_1845_Fig4_HTML.png)
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases. 2014;2(12):852. https://doi.org/10.12998/wjcc.v2.i12.852.
Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol. 1972;58:642–6. https://doi.org/10.1093/ajcp/58.6.642.
Martinez-Ramos D, Simon-Monterde L, Suelves-Piqueres C, Queralt-Martin R, Granel-Villach L, Laguna-Sastre JM, Nicolau MJ, Escrig-Sos J. Idiopathic granulomatous mastitis: a systematic review of 3060 patients. Breast J. 2019;25:1245–50. https://doi.org/10.1111/tbj.13446.
Wolfrum A, Kümmel S, Theuerkauf I, Pelz E, Reinisch M. Granulomatous mastitis: a therapeutic and diagnostic challenge. Breast Care. 2018;13:413–8. https://doi.org/10.1159/000495146.
Altintoprak F, Karakece E, Kivilcim T, Dikicier E, Cakmak G, Celebi F, Ciftci IH. Idiopathic granulomatous mastitis: an autoimmune disease? Sci World J. 2013. https://doi.org/10.1155/2013/148727.
Fujii M, Mizutani Y, Sakuma T, Tagami K, Okamoto K, Kuno Y, Harada M, Kubouchi K, Tsutsumi Y. Corynebacterium kroppenstedtii in granulomatous mastitis: analysis of formalin-fixed, paraffin-embedded biopsy specimens by immunostaining using low-specificity bacterial antisera and real-time polymerase chain reaction. Pathol Int. 2018;68:409–18. https://doi.org/10.1111/pin.12683.
Farouk O, Abdelkhalek M, Abdallah A, Shata A, Senbel A, Attia E, Elghaffar MA, Mesbah M, Soliman N, Amin M, El-Tantawy D. Rifampicin for idiopathic granulomatous lobular mastitis: a promising alternative for treatment. World J Surg. 2017;41:1313–21. https://doi.org/10.1007/s00268-016-3857-7.
Al-Khaffaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experience. J Am Coll Surg. 2008;206:269–73. https://doi.org/10.1016/j.jamcollsurg.2007.07.041.
Taylor GB, Paviour SD, Musaad S, Jones WO, Holland DJ. A clinicopathological review of 34 cases of inflammatory breast disease showing an association between Corynebacteria infection and granulomatous mastitis. Pathology. 2003;35:109–19. https://doi.org/10.1080/0031302031000082197.
Dobinson HC, Anderson TP, Chambers ST, Doogue MP, Seaward L, Werno AM. Antimicrobial treatment options for granulomatous mastitis caused by Corynebacterium species. J Clin Microbiol. 2015;53:2895–9. https://doi.org/10.1128/jcm.00760-15.
Oddó D, Domínguez F, Gómez N, Méndez GP, Navarro ME. Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast. Sage Open Med Case Rep. 2019;7:2050313x19836583. https://doi.org/10.1177/2050313x19836583.
Tauch A, Fernández-Natal I, Soriano F. A microbiological and clinical review on Corynebacterium kroppenstedtii. Int J Infect Dis. 2016;48:33–9. https://doi.org/10.1016/j.ijid.2016.04.023.
Wang J, Xu H, Li Z, Li F, Yang Y, Yu X, Jiang D, **ng L, Sun H, Shao M. Pathogens in patients with granulomatous lobular mastitis. Int J Infect Dis. 2019;81:123–7. https://doi.org/10.1016/j.ijid.2019.01.034.
Wang S, Lin J, Li C, Lee Y-H. A successful case of etanercept used for idiopathic granulomatous mastitis. Breast J. 2019;25:343–5. https://doi.org/10.1111/tbj.13219.
Koksal H. Human leukocyte antigens class I and II in patients with idiopathic granulomatous mastitis. Am J Surg. 2019;218:605–8. https://doi.org/10.1016/j.amjsurg.2019.01.038.
Yigitbasi MR, Guntas G, Atak T, Sonmez C, Yalman H, Uzun H. The role of interleukin-33 as an inflammatory marker in differential diagnosis of idiopathic granulomatous mastitis and breast cancer. J Invest Surg. 2016;30:1–5. https://doi.org/10.1080/08941939.2016.1240270.
Mazlan L, Suhaimi SNA, Jasmin SJ, Latar NHM, Adzman S, Muhammad R. Breast carcinoma occurring from chronic granulomatous mastitis. Malays J Med Sci Mjms. 2011;19:82–5.
Islam RA, Hossain S, Chowdhury EH. Potential therapeutic targets in energy metabolism pathways of breast cancer. Curr Cancer Drug Target. 2017;17:707–21. https://doi.org/10.2174/1568009617666170330150458.
Lei Q-R, Yang X, Miao C-M, Wang J-C, Yang Y. Relationship between granulomatous lobular mastitis and methylene tetrahydrofolate reductase gene polymorphism. World J Clin Cases. 2020;8:4017–21. https://doi.org/10.12998/wjcc.v8.i18.4017.
Simsek HU, Albayrak MGB, Kasap M, Simsek T, Akpinar G, Guler SA, Canturk NZ. Elucidation of the changes occurring at the proteome level in ovaries of high-fat diet-induced obese rats. Cell Biochem Funct. 2022;40:278–97. https://doi.org/10.1002/cbf.3693.
Ocal K, Dag A, Turkmenoglu O, Kara T, Seyit H, Konca K. Granulomatous mastitis: clinical, pathological features, and management. Breast J. 2010;16:176–82. https://doi.org/10.1111/j.1524-4741.2009.00879.x.
Tang ELS, Ho CSB, Chan PMY, Chen JJC, Goh MH, Tan EY. The therapeutic dilemma of idiopathic granulomatous mastitis. Ann Acad Med Singap. 2021;50:598–605. https://doi.org/10.47102/annals-acadmedsg.2020645.
Goulabchand R, Hafidi A, de Perre PV, Millet I, Maria ATJ, Morel J, Quellec AL, Perrochia H, Guilpain P. Mastitis in autoimmune diseases: review of the literature diagnostic pathway, and pathophysiological key players. J Clin Med. 2020;9:958. https://doi.org/10.3390/jcm9040958.
Robinson MD, Smyth GK. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics. 2008;9:321–32. https://doi.org/10.1093/biostatistics/kxm030.
Feng C, Wang H, Lu N, Chen T, He H, Lu Y, Tu XM. Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry. 2014;26:105–9. https://doi.org/10.3969/j.issn.1002-0829.2014.02.009.
Mutch DM, Berger A, Mansourian R, Rytz A, Roberts M-A. The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinform. 2002;3:17–17. https://doi.org/10.1186/1471-2105-3-17.
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, von Mering C. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018;47:D607–13. https://doi.org/10.1093/nar/gky1131.
Kamal RM, Hamed ST, Salem DS. Classification of inflammatory breast disorders and step by step diagnosis. Breast J. 2009;15:367–80. https://doi.org/10.1111/j.1524-4741.2009.00740.x.
Limninart N, Harvey JA, Schultz KJ, Mills AM, Noland MMB, Schroen AT, Rochman CM. What do you mean it’s not cancer? A review of autoimmune and systemic inflammatory diseases involving the breast. J Breast Imaging. 2021;3:612–25. https://doi.org/10.1093/jbi/wbab029.
Steuer AB, Stern MJ, Cobos G, Castilla C, Joseph K-A, Pomeranz MK, Femia AN. Clinical characteristics and medical management of idiopathic granulomatous mastitis. Jama Dermatol. 2020;156:460–4. https://doi.org/10.1001/jamadermatol.2019.4516.
Torun B, Bilgin A, Orhan D, Gocmen R, Kılıc SS, Kuskonmaz B, Cetinkaya D, Tezcan I, Cagdas D. Combined immunodeficiency due to purine nucleoside phosphorylase deficiency: outcome of three patients. Eur J Med Genet. 2022;65: 104428. https://doi.org/10.1016/j.ejmg.2022.104428.
Bantia S, Miller PJ, Parker CD, Ananth SL, Horn LL, Kilpatrick JM, Morris PE, Hutchison TL, Montgomery JA, Sandhu JS. Purine nucleoside phosphorylase inhibitor BCX-1777 (immucillin-H)—a novel potent and orally active immunosuppressive agent. Int Immunopharmacol. 2001;1:1199–210. https://doi.org/10.1016/s1567-5769(01)00056-x.
Balakrishnan K, Nimmanapalli R, Ravandi F, Keating MJ, Gandhi V. Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells. Blood. 2006;108:2392–8. https://doi.org/10.1182/blood-2006-03-007468.
Sunder SR, Hanumanth SR, Gaddam S, Jonnalagada S, Valluri VL. Association of TAP 1 and 2 gene polymorphisms with human immunodeficiency virus–tuberculosis co-infection. Hum Immunol. 2011;72:908–11. https://doi.org/10.1016/j.humimm.2011.07.304.
Wang Y, Shu Y, **ao Y, Wang Q, Kanekura T, Li Y, Wang J, Zhao M, Lu Q, **ao R. Hypomethylation and overexpression of ITGAL (CD11a) in CD4+ T cells in systemic sclerosis. Clin Epigenet. 2014;6:25. https://doi.org/10.1186/1868-7083-6-25.
Twigger A-J, Küffer GK, Geddes DT, Filgueria L. Expression of granulisyn, perforin and granzymes in human milk over lactation and in the case of maternal infection. Nutrients. 2018;10:1230. https://doi.org/10.3390/nu10091230.
Abendaño N, Esparza-Baquer A, Bernales I, Reina R, de Andrés D, Jugo BM. Gene expression profiling reveals new pathways and genes associated with Visna/Maedi viral disease. Animals. 2021;11:1785. https://doi.org/10.3390/ani11061785.
Mathieu A-L, Verronese E, Rice GI, Fouyssac F, Bertrand Y, Picard C, Chansel M, Walter JE, Notarangelo LD, Butte MJ, Nadeau KC, Csomos K, Chen DJ, Chen K, Delgado A, Rigal C, Bardin C, Schuetz C, Moshous D, Reumaux H, Plenat F, Phan A, Zabot M-T, Balme B, Viel S, Bienvenu J, Cochat P, van der Burg M, Caux C, Kemp EH, Rouvet I, Malcus C, Méritet J-F, Lim A, Crow YJ, Fabien N, Ménétrier-Caux C, Villartay J-PD, Walzer T, Belot A. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity. J Allergy Clin Immunol. 2015;135:1578-88.e5. https://doi.org/10.1016/j.jaci.2015.01.040.
Zhu Q, Wang L, Wang P. The identification of gene expression profiles associated with granulomatous mastitis. Breast Care. 2021;16:319–27. https://doi.org/10.1159/000507474.
Zhang Y, Yang W, Wen G, Tang H, Wu C, Wu Y, **g Z, Tang M, Liu G, Li D, Li Y, Deng Y. High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival. Mol Genetics Genom Med. 2019;7: e908. https://doi.org/10.1002/mgg3.908.
Richardson B, Yung R. Role of DNA methylation in the regulation of cell function. J Lab Clin Med. 1999;134:333–40. https://doi.org/10.1016/s0022-2143(99)90147-6.
Xu K, Wang R, **e H, Hu L, Wang C, Xu J, Zhu C, Liu Y, Gao F, Li X, Wang C, Huang J, Zhou W, Zhou G, Shu Y, Guan X. Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis. Oncogenesis. 2021;10:66. https://doi.org/10.1038/s41389-021-00355-6.
Kim J-Y, Jung HH, Sohn I, Woo SY, Cho H, Cho EY, Lee JE, Kim SW, Nam SJ, Park YH, Ahn JS, Im Y-H. Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer. Breast Cancer Res Treat. 2020;184:325–34. https://doi.org/10.1007/s10549-020-05874-1.
Mollinedo F. Neutrophil degranulation, plasticity, and cancer metastasis. Trends Immunol. 2019;40:228–42. https://doi.org/10.1016/j.it.2019.01.006.
Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–80. https://doi.org/10.1053/j.gastro.2007.03.059.
de Luca C, Olefsky JM. Inflammation and insulin resistance. Febs Lett. 2008;582:97–105. https://doi.org/10.1016/j.febslet.2007.11.057.
Acknowledgements
This study was supported by Kocaeli University Scientific Research Projects Coordination Unit under Grant no. 2019/092.
Funding
This study was supported by Kocaeli University Scientific Research Projects Coordination Unit under Grant no. 2019/092.
Author information
Authors and Affiliations
Contributions
Study conception and experimental design were performed by MGBA, MK, and GA. Tissue collection with surgeries and storage were performed by TS, ZC, and SAG. Sample preparation and protein isolation were performed by MGBA and TŞ. Western Blot analysis, LC–MS/MS analysis and MS analysis were performed by MGB, MK, and GA. Bioinformatic analysis were performed by MGBA and GA. The first draft of the manuscript was written by MGBA. Writing, review, and editing the draft were performed by GA and MK. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
The Kocaeli University Ethics Committee has approved this work (approval numbers: KU GOKAEK-2019/16.05 2019/140). To protect the human subjects and maintain high ethical standards, Declaration of Helsinki was followed. All patients provided their written informed consents, and all the procedures were performed at Kocaeli University Hospital.
Consent to participate
Informed consents, approved by the ethics committee, were acquired from each patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Albayrak, M.G.B., Simsek, T., Kasap, M. et al. Tissue proteome analysis revealed an association between cancer, immune system response, and the idiopathic granulomatous mastitis. Med Oncol 39, 238 (2022). https://doi.org/10.1007/s12032-022-01845-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-022-01845-2